Ligand validation:6RUJ

OGA: N-OXALYLGLYCINE

OGA is a Ligand Of Interest in 6RUJ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RUJ_OGA_A_502	59%	8%	0.198	0.983	2.37	2.31	3	4	0	0	100%	1
1H2K_OGA_A_1351	93%	3%	0.074	0.969	4.89	1.47	3	2	0	0	100%	1
6HL6_OGA_A_410	89%	19%	0.093	0.972	2.36	1.12	3	-	0	0	100%	1
6HKP_OGA_A_412	82%	14%	0.103	0.957	2.4	1.51	3	1	0	0	100%	1
6HC8_OGA_A_402	80%	13%	0.116	0.965	2.47	1.48	3	1	0	0	100%	1
4Z1V_OGA_A_601	74%	20%	0.149	0.98	2.28	1.14	1	-	0	0	100%	1
4GJY_OGA_A_502	99%	25%	0.056	0.993	2.38	0.72	2	-	0	0	100%	1
3MS5_OGA_A_390	99%	26%	0.048	0.984	1.22	1.76	1	3	0	0	100%	1
5A1F_OGA_A_1756	99%	17%	0.054	0.985	2.18	1.44	2	2	0	0	100%	1
6F4T_OGA_A_502	98%	14%	0.053	0.979	2.26	1.62	4	2	0	0	100%	1
6F4R_OGA_A_502	98%	20%	0.062	0.984	1.98	1.4	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.